3906 results for «2022»

Filter By

3906 results

First Patients Outside of U.S. Treated with TRIA Biopolymer Surgical Aortic Heart Valve in India Clinical Trial

03 May 2022

One-month ticagrelor monotherapy after PCI in acute coronary syndromes: Principal results from the double-blind, placebo-controlled Ultimate DAPT trial

07 Apr 2024

Elad Asher provides his take on the ULTIMATE-DAPT Trial results which Gregg W Stone presented at ACC.24 in Atlanta.

Elad Asher

Author

Elad Asher
One-month ticagrelor monotherapy after PCI in acute coronary syndromes: Principal results from the double-blind, placebo-controlled Ultimate DAPT trial

Predicting the unpredictable: application of predictive modeling in complex transcatheter aortic valve replacement

13 Dec 2023

This case highlights the potential add-on value of reduced-order computational modeling over standard CT scan analysis due to its ability to predict the interaction of different devices or sizes with the patient-specific anatomy.

Predicting the unpredictable: application of predictive modeling in complex transcatheter aortic valve replacement

Positive Results Revealed in Clinical Trial COMPARE 60/80 for High Bleeding Risk Patients

26 Oct 2023

BioCardia announces FDA approval of IND application for allogeneic NK1R+ human mesenchymal stem cells for ischemic heart failure

06 Dec 2022

P2Y12 inhibitor monotherapy vs DAPT after PCI with BP-EES: The SHARE Randomized Clinical Trial

26 Aug 2023

Elad Asher provides his take on the final results of the SHARE (SHort-term Dual Antiplatelet Therapy After Deployment of BioabsoRbable Polymer Everolimus-Eluting Stent) trial, which were presented during the ESC 2023 congress in Amsterdam by Pil-Ki Min.

Elad Asher

Author

Elad Asher
SHARE trial: P2Y12 inhibitor monotherapy vs DAPT after PCI

Protein and exercise to reverse frailty in older men and women undergoing transcatheter aortic valve replacement: The PERFORM-TAVR Trial

08 Apr 2024

Panos Xaplanteris provides his take on the results of PERFORM-TAVR presented by Jonathan Afilalo at ACC.24 in Atlanta.

Panagiotis Xaplanteris

Author

Panagiotis Xaplanteris
PERFORM-TAVR: Protein and exercise to reverse frailty in older patients undergoing TAVR

Efficacy and safety of Edoxaban in anticoagulant therapy early after surgical bioprosthetic valve replacement: ENBALV trial

16 Nov 2024

Edoardo Zancanaro provides his take on the ENBALV trial presented by Chisato Izumi at AHA 2024 in Chicago.

Edoardo Zancanaro

Author

Edoardo Zancanaro
ENBALV

Comparison of puncture success rate between distal radial access and transradial access in patients with ST-elevation myocardial infarction (DRAMI)

07 Nov 2024

Aaysha Cader provides her take on the DRAMI trial presented by Jun-Won Lee at TCT 2024 in Washington.

Author

Aaysha Cader
Comparison of puncture success rate between distal radial access and transradial access in patients with STEMI (DRAMI)

TAVI: a fascinating 20-year-long odyssey with a happy ending

10 Nov 2017

This new "disruptive" technology is among the most important medical breakthroughs to date. TAVI emerged in 2002 to profoundly alter the landscape of cardiovascular medicine.

TAVI: a fascinating 20-year-long odyssey with a happy ending.

EuroPCR 2024 delivered an eye-opening focus on imaging guidance

24 May 2024

A record 12,100 participants from 130 countries have just taken part in the highly educational WorldLeading Course in interventional cardiovascular medicine. They enjoyed a unique opportunity to exchange their knowledge, skills and experience on a global scale.

Paris – France, 17 May 2024. As always, the thought-provoking...

MATTERHORN - Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation

01 Sep 2024

Yohei Ohno provides his takeaways from the results of the MATTERHORN trial presented by Volker Rudolph at the ESC Congress 2024 in London.

Yohei Ohno

Author

Yohei Ohno
MATTERHORN

Use of advanced coronary techniques in bailout of aortic valvuloplasty balloon entrapment

25 Mar 2025

Balloon entrapment in valvuloplasty can be life-threatening, especially after balloon rupture. Learn about a new technique involving balloon internalisation and safety snares for successful retrieval and sheath upsizing.

Aortic valvuloplasty balloon entrapment

Complicated subendothelial dissection during left anterior descending coronary artery – first diagonal branch bifurcation treatment with Culotte technique

06 Jan 2025

Learn more about troubleshooting and tailor-made treatment combining 2D and 3D OCT thanks to this image in cardiology!

Troubleshooting of a complicated subendothelial dissection using 2D and 3D OCT

FFR or 3d-quantitative coronary angiography-based vessel-FFR guided revascularisation – The FAST III trial

28 Mar 2026

Chiara De Biase provides her take on the FAST III Trial presented by Joost Daemen at ACC.26 in New Orleans. She reviews the comparison between vFFR and FFR, highlighting key findings and their impact on revascularisation strategies.

Author

Chiara De Biase
FAST III: FFR vs 3D-QCA vessel-guided revascularisation

Data from benchmark registry demonstrate improved TAVR efficiency with preserved patient safety

17 May 2023

MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval

24 Oct 2022

Concept Medical granted Investigational Device Exemption (IDE) approval for their Magic Touch Sirolimus Coated Balloon for the treatment of Below the Knee (BTK) arterial disease

11 Feb 2023

Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

08 Jan 2025

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

Author

Bruno Scheller
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation

01 Sep 2024

Make the most of the insights from Jacob Thomsen Loenborg’s interview with Chiara De Biase and Ali Nazmi Calik’s article to capture the key takeaways from this trial, simultaneously published in the NEJM, presented at the ESC Congress 2024 in London.

Author

Chiara De Biase
Jacob Lønborg

Author

Jacob Lønborg

Author

Ali Nazmi Calik
NOTION 3
Didn’t find what you were looking for?